Biometric Identification / Cybersecurity SaaS Solutions Provider BIO-key Presents at DealFlow Discovery Investor Conference Jan. 28 & 29 in Atlantic City, NJ
MWN-AI** Summary
BIO-key International, Inc. (NASDAQ: BKYI), a prominent provider of biometric identity and access management SaaS solutions, is set to present at the DealFlow Discovery Conference on January 28 and 29, 2026, at the Borgata hotel in Atlantic City, New Jersey. This event will connect institutional investors, family offices, and high-net-worth individuals with innovative companies in a variety of high-growth sectors.
CEO Mike DePasquale will represent BIO-key, providing insights into the company's offerings that focus on phoneless, tokenless, passwordless, and phish-resistant authentication solutions. Attendees will have the opportunity for 1-on-1 meetings with the CEO, facilitating direct engagement regarding BIO-key's strategic direction and market potential.
The Discovery Conference, previously known as The Microcap Conference, aims to spotlight high-growth companies and enhance visibility for both public and private firms. The platform will offer a variety of interactive sessions, expert discussions on capital raising, and networking opportunities, all designed to foster investor-company relationships.
BIO-key International stands out in the cybersecurity space by revolutionizing traditional authentication methods through its biometric-centric multi-factor identity and access management software. With over 40 million users, BIO-key’s solutions provide customers with flexible authentication options suited for diverse operational needs. The company’s PortalGuard IAM solution is designed for both cloud-hosted and on-premise deployments, making it a cost-effective choice for securing access to sensitive information and high-value transactions.
Further details about BIO-key’s presentation and registration for the Discovery Conference can be found on the event's official website. Interested investors are encouraged to leverage this opportunity to learn about the company’s innovative technologies and market strategies.
MWN-AI** Analysis
As a leading provider of biometric-enabled Identity and Access Management (IAM) solutions, BIO-key International, Inc. (NASDAQ: BKYI) is strategically positioned within a rapidly growing cybersecurity landscape. The company focuses on phoneless, tokenless, and passwordless authentication, catering to an increasing demand for robust security measures that protect against cyber threats, especially in the wake of rising data breaches and privacy concerns.
The upcoming DealFlow Discovery Investor Conference on January 28-29, 2026, presents a significant opportunity for BIO-key to showcase its innovative solutions to institutional investors, family offices, and high-net-worth individuals. The CEO, Mike DePasquale, will deliver a presentation that could enhance market visibility and attract investment interest. Investors seeking exposure to high-growth sectors should keep a close watch on the insights shared during this conference, as it will likely highlight key trends facing the cybersecurity market and specific strategic initiatives by BIO-key.
Investors should consider the following factors when evaluating BIO-key:
1. **Market Demand:** The growing shift towards biometric authentication solutions suggests substantial growth potential. With over 40 million users already secured by BIO-key's technology, the company has demonstrated its ability to capture and serve a significant market share.
2. **Technological Advancements:** BIO-key’s commitment to continuous innovation in IAM solutions positions it ahead of many competitors. Their ability to offer flexible deployment options—both cloud-hosted and on-premise—enhances their attractiveness to a diverse client base.
3. **Financial Health:** Evaluating BIO-key’s financial statements post-conference will be crucial, especially engagement metrics from attendees and any partnership announcements.
4. **Regulatory Environment:** Understanding the regulatory landscape surrounding cybersecurity will provide insights into future growth potential and compliance challenges.
Investors are encouraged to engage proactively with BIO-key's representatives at the conference and assess whether its growth trajectory aligns with their investment strategies in the cybersecurity sector.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
ATLANTIC CITY, N.J. and HOLMDEL, N.J., Dec. 23, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), a leading provider of biometric enabled Identity and Access Management SaaS solutions for phoneless, tokenless, passwordless, and phish-resistant authentication, will participate at the DealFlow Discovery Conference Wednesday and Thursday, January 28th and 29th at the Borgata hotel in Atlantic City, New Jersey. Institutional investors, family offices and high-net-worth investors are invited to attend at no cost.
BIO-key CEO Mike DePasquale will present at DealFlow Discovery and will be available for 1-on-1 meetings throughout the event. BIO-key’s presentation details will be posted on DealFlow’s website in January.
Registration:
Click here: https://dealflowdiscoveryconference.com/registration/ to register for the Discovery Conference.
About The DealFlow Discovery (www.dealflowdiscoveryconference.com)
The DealFlow Discovery Conference is where high-growth companies come to be discovered. Formerly known as The Microcap Conference, the event has been expanded to include both publicly traded microcaps and qualified private companies across a variety of high-growth sectors.
Organized by DealFlow Events, the conference brings together hundreds of companies, investors, and dealmakers for two days of company presentations, expert discussions on raising capital, unlimited 1-on-1 meetings, interactive sessions and networking opportunities. The Discovery Conference delivers a high visibility platform for companies to showcase their value propositions to a broad base of prospective investors.
Keynote presentations and panel discussions led by renowned industry figures will provide insights on business, investing, entrepreneurial success, and other trends in US equity markets, from capital formation to regulatory updates, tailored to the public microcap and private market communities.
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
| Engage with BIO-key: | |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| X – Corporate: | @BIOkeyIntl |
| X – Investors: | @BIO_keyIR |
| StockTwits: | BIO_keyIR |
Investor Contacts:
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800
FAQ**
How does BIO-key International Inc. BKYI plan to leverage its biometric authentication solutions in the evolving regulatory landscape presented at the DealFlow Discovery Conference in Atlantic City, NJ?
What specific growth sectors is BIO-key International Inc. BKYI targeting for expansion, as highlighted during the presentations at the DealFlow Discovery Conference?
In what ways will BIO-key International Inc. BKYI engage with institutional investors and high-net-worth attendees during the one-on-one meetings at the DealFlow Discovery Conference in Atlantic City?
How can the insights shared by industry experts at the DealFlow Discovery Conference influence BIO-key International Inc. BKYI’s strategic direction moving forward in the competitive IAM market?
**MWN-AI FAQ is based on asking OpenAI questions about BIO-key International Inc. (NASDAQ: BKYI).
NASDAQ: BKYI
BKYI Trading
-7.92% G/L:
$0.6031 Last:
195,851 Volume:
$0.63 Open:
